RecruitingNot ApplicableNCT06068647

Ultrasound and Respiratory Physiological Signals in Lung Diseases

Synergistic Assessment of Ultrasound Data and Respiratory physiOlogical Signals in luNg Diseases


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

25 participants

Start Date

Mar 22, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The use of lung ultrasound is instrumental in the evaluation of many chest pathologies and its ability to detect pleuro-pulmonary pathology is widely accepted. However, the use of ultrasound to explore the state of the peripheral lung parenchyma, when the organ is still aerated, is a relatively new application. Horizontal and vertical artifacts are separate and distinct artifacts that can be seen during ultrasound examination of the lungs. While the practical role of lung ultrasound artifacts is accepted to detect and monitor many conditions, further research is needed for the physical interpretation of ultrasound artifacts. These artifacts are diagnostic signs, but we don't fully understand their origin. The artifactual information deriving from the surface acoustic interaction, beyond the pleural line, in the ultrasound images of the normally aerated and non-deflated lung, represents the final result of complex interactions of acoustic waves with a specific three-dimensional structure of the biological tissue. Thus, the umbrella term "vertical artifacts" oversimplifies many physical phenomena associated with a pathological pleural plane. There is growing evidence that vertical artifacts are caused by physiological and pathological changes in the superficial lung parenchyma. Therefore, the need emerges to explore the physical phenomena underlying the artifactual ultrasound information deriving from the surface acoustic interaction of ultrasound with the pleuro-pulmonary structures.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study monitors lung disease patients using a combination of ultrasound imaging and wearable sensors that measure breathing patterns and other physiological signals. The goal is to better understand and track lung conditions in real time. **You may be eligible if...** - You are hospitalized with a flare-up (exacerbation) of interstitial lung disease or infectious pneumonia (not COVID-19), OR - You are an outpatient with emphysema or COPD in a stable phase - You can provide written informed consent **You may NOT be eligible if...** - You have a history of skin irritation or allergic reactions to adhesives or hydrogels (used with the wearable sensors) - You have a family history of relevant allergies to sensor materials Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTLung ultrasound, computed tomographic scan and patch-based cardio-respiratory evaluations

Ultrasonographic findings will be obtained with machines supplied with clinical Units. Additionally, US scans as acquired with open research platform will also be gathered. For both scanners, ultrasonographic scans will be performed and videos will be recorded and stored in each landmark. Metal cutaneous landmarks will be positioned and left during computed tomographic (CT) scans, indicating the areas of ultrasonographic assessment. Finally, on the same day of enrolment, a wearable system for measuring physiological signals, will be applied. Within the scope of this study, sensors will be applied to the upper chest. The following information will be collected by each sensor: electrocardiography, respiratory effort, respiratory flow, activity, position, and sound pressure level.


Locations(1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Rome, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06068647


Related Trials